Enzyme-responsive multistage vector for drug delivery to tumor tissue. (November 2016)

• Record Type: Journal Article
• Authors: Mi, Yu; Wolfram, Joy; Mu, Chaofeng; Liu, Xuewu; Blanco, Elvin; Shen, Haifa; Ferrari, Mauro
• Is Part Of: Pharmacological research. Volume 113(2016:Nov.)Part A
• Page Start: 92
• Page End: 99
• Publication Date: 2016-11
• Subjects: Enzyme-responsive release -- Lung metastasis -- MMP2 -- Multistage vector -- Porous silicon; Pharmacology -- Periodicals; Pharmacology -- Periodicals; Research -- Periodicals; Médicaments -- Recherche -- Périodiques; Pharmacologie -- Périodiques; 615.105
• DOI: 10.1016/j.phrs.2016.08.024
• Languages: English
• ISSNs: 1043-6618

Abstract

Graphical abstract: Abstract: Various nanodelivery systems have been designed to release therapeutic agents upon contact with specific enzymes. However, enzyme-triggered release typically takes place in the tissue interstitium, thereby resulting in the extracellular delivery of drugs. Here, we have designed an enzyme-stimulated multistage vector (ESMSV), which enables stimulus-triggered release of drug-encapsulated nanoparticles from a microparticle. Specifically, polymeric nanoparticles with a surface matrix metalloproteinase-2 (MMP2) peptide substrate were conjugated to the surface of porous silicon microparticles. In the presence of MMP2, the polymeric nanoparticles were released into the tumor interstitium. This platform can be used to attain triggered drug release, while simultaneously facilitating the cellular internalization of drugs. The results indicate that nanoparticle release was MMP2-specific and resulted in improved intracellular uptake of hydrophobic agents in the presence of MMP2. Furthermore, in a mouse model of melanoma lung metastasis, systemic delivery of ESMSVs caused a substantial increase in intracellular accumulation of agents in cancer cells in comparison to delivery with non-stimulus-responsive particles.